18 February 2022>: Original Paper
Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States
Shingo Shimada 1ADEF , Toshihiro Kitajima 1BCE , Yukiko Suzuki 1BD , Yasutaka Kuno 1BD , Tayseer Shamaa 1BC , Tommy Ivanics 1BCE , Kelly Collins 1DE , Michael Rizzari 1BD , Atsushi Yoshida 1BD , Marwan Abouljoud 1BD , Dilip Moonka 2BD , Shunji Nagai 1ACE*DOI: 10.12659/AOT.934850
Ann Transplant 2022; 27:e934850
Table 9 Cause of 1-year death in patient who underwent liver transplant alone between the eras.
n (%) | Overalln=14 (14.7) | Before the 2017 policyn=8 (20.0) | After the 2017 policyn=6 (10.9) |
---|---|---|---|
Graft failure, n (%) | 0 (0) | 0 (0) | 0 (0) |
Infection, n (%) | 8 (57.1) | 6 (75.0) | 2 (33.3) |
Brain hemorrhage, infarction, n (%) | 1 (7.1) | 0 (0) | 1 (16.7) |
Multi organ failure, n (%) | 2 (14.3) | 2 (25.0) | 0 (0) |
Others, n (%) | 3 (21.4) | 0 (0) | 3 (50.0) |
LTA – liver transplant alone. |